179 related articles for article (PubMed ID: 15831978)
1. Passive stent coatings in the drug-eluting era.
Menown I; Lowe R; Penn I
J Invasive Cardiol; 2005 Apr; 17(4):222-8. PubMed ID: 15831978
[TBL] [Abstract][Full Text] [Related]
2. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
Pendyala L; Jabara R; Robinson K; Chronos N
J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
[TBL] [Abstract][Full Text] [Related]
3. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of drug-eluting stents: current best available evidence.
Raja SG; Dreyfus GD
J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
[TBL] [Abstract][Full Text] [Related]
5. [Progress on reasech of drug-coated stent].
Zhang L; Liu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):235-9. PubMed ID: 17333930
[TBL] [Abstract][Full Text] [Related]
6. Role of stent design and coatings on restenosis and thrombosis.
Hara H; Nakamura M; Palmaz JC; Schwartz RS
Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
[TBL] [Abstract][Full Text] [Related]
7. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.
Lepor NE; Madyoon H; Kereiakes D
Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234
[TBL] [Abstract][Full Text] [Related]
8. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
9. Stent thrombosis in the era of drug eluting stents.
Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
[TBL] [Abstract][Full Text] [Related]
10. Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
Birkenhauer P; Yang Z; Gander B
J Pharm Pharmacol; 2004 Nov; 56(11):1339-56. PubMed ID: 15525440
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
12. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
Ducrocq G; Serebruany V; Tanguay JF
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
[TBL] [Abstract][Full Text] [Related]
14. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent safety.
Slottow TL; Waksman R
Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
[TBL] [Abstract][Full Text] [Related]
16. Still a future for the bare metal stent?
Barlis P; Di Mario C
Int J Cardiol; 2007 Sep; 121(1):1-3. PubMed ID: 17360051
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
[TBL] [Abstract][Full Text] [Related]
18. Very late thrombosis after sirolimus-eluting stent implantation.
Pasceri V; Pelliccia F; Cianfrocca C; Pristipino C; Santini M; Richichi G
J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):438-42. PubMed ID: 16721209
[TBL] [Abstract][Full Text] [Related]
19. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
[TBL] [Abstract][Full Text] [Related]
20. The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention.
Dilmanian H; Aronow WS; Mundia M; Pucillo AL; Weiss MB; Kalapatapu K; Monsen CE
Am J Ther; 2007; 14(3):277-9. PubMed ID: 17515704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
